Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Pediatric Growth Hormone Deficiency
Clinical Trial
NCT02968004Last updated: 12/4/2025
OPK
OPKO HEALTH, INC.